Skip to main content

Table 2 Association of PRS, APOE ε4 status, hippocampal volume on MRI, and amyloid PET positivity with disease progression to dementia according to z-scores in all MCI participants, MCI with APOE ε4, and MCI without APOE ε4

From: Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment

 

HR (95% CI), P-value

 

All MCI

(n = 732)

MCI with APOE ε4

(n = 378)

MCI without APOE ε4

(n = 353)

PRS+APOE

1.468 (1.335–1.615)

2.30 × 10–15

1.167 (1.005–1.355)

4.16 × 10–2

1.710 (1.244–2.351)

9.30 × 10–4

PRSAPOE

1.293 (1.157–1.445)

5.19 × 10–6

1.172 (1.020–1.346)

2.47 × 10–2

1.429 (1.182–1.728)

2.19 × 10–4

APOE ε4 carrier status

2.678 (2.066–3.470)

9.70 × 10–14†

NA

NA

Hippocampal volume on MRI

0.563 (0.502–0.632)

 < 2.00 × 10–16*

0.538 (0.461–0.628)

3.55 × 10–15†

0.536 (0.435–0.660)

4.44 × 10–9††

Amyloid PET positivity

7.449 (4.199–13.215)

6.61 × 10–12§

5.011 (1.966–12.764)

7.31 × 10–4

6.500 (2.914–14.495)

4.77 × 10–6¶

  1. PRS+APOE: PRS including SNPs within the 1 Mb-region surrounding the APOE gene; PRSAPOE: PRS excluding SNPs within the 1 Mb-region surrounding the APOE gene
  2. Cox regression analysis of all variables were adjusted with age and sex, and additionally with MRI field strength in hippocampal volume analysis
  3. Data unavailable for * 3 subjects, 1 subject, †† 2 subjects, § 343 subjects, 191 subjects, and 152 subjects